DE68910676D1 - Verwendung von Creosot als antispastischer Wirkstoff. - Google Patents

Verwendung von Creosot als antispastischer Wirkstoff.

Info

Publication number
DE68910676D1
DE68910676D1 DE89122575T DE68910676T DE68910676D1 DE 68910676 D1 DE68910676 D1 DE 68910676D1 DE 89122575 T DE89122575 T DE 89122575T DE 68910676 T DE68910676 T DE 68910676T DE 68910676 D1 DE68910676 D1 DE 68910676D1
Authority
DE
Germany
Prior art keywords
creosot
antispastic agent
antispastic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89122575T
Other languages
English (en)
Other versions
DE68910676T2 (de
Inventor
Tatsuya Baba
Norio Ogata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiko Pharmaceutical Co Ltd
Original Assignee
Taiko Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiko Pharmaceutical Co Ltd filed Critical Taiko Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE68910676D1 publication Critical patent/DE68910676D1/de
Publication of DE68910676T2 publication Critical patent/DE68910676T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE68910676T 1989-06-01 1989-12-07 Verwendung von Creosot als antispastischer Wirkstoff. Expired - Lifetime DE68910676T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14082089 1989-06-01
JP1247781A JPH0625056B2 (ja) 1989-06-01 1989-09-21 鎮痙剤

Publications (2)

Publication Number Publication Date
DE68910676D1 true DE68910676D1 (de) 1993-12-16
DE68910676T2 DE68910676T2 (de) 1994-05-26

Family

ID=26473230

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68910676T Expired - Lifetime DE68910676T2 (de) 1989-06-01 1989-12-07 Verwendung von Creosot als antispastischer Wirkstoff.

Country Status (8)

Country Link
US (1) US5112872A (de)
EP (1) EP0400219B1 (de)
JP (1) JPH0625056B2 (de)
KR (1) KR910000130A (de)
CA (1) CA2005072C (de)
DE (1) DE68910676T2 (de)
HK (1) HK2194A (de)
PH (1) PH27336A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2545321B2 (ja) * 1992-08-21 1996-10-16 大幸薬品株式会社 平滑筋収縮抑制剤
GB9308469D0 (en) * 1993-04-23 1993-06-09 Wright George H Management of cholelithiasis
JP3074519B2 (ja) * 1996-07-01 2000-08-07 大幸薬品株式会社 腸液吸収促進剤
JP2006192922A (ja) * 2005-01-11 2006-07-27 Shigeru Co Ltd 車両用内装品における装着凹部の形成方法
US20060287347A1 (en) * 2005-06-21 2006-12-21 Aberg A K G Methods for treating smooth muscle disorders using trospium
US7390816B2 (en) * 2005-06-21 2008-06-24 Bridge Pharma, Inc. Methods for treating urinary incontinence in patients suffering from memory disorders
US20070004766A1 (en) * 2005-07-01 2007-01-04 Aberg A K G Methods for relaxation of smooth muscle contractions using Trospium
CN104334163B (zh) * 2012-03-28 2017-09-12 大幸药品株式会社 医药组合物及密封该医药组合物而成的软胶囊剂
JP7455852B2 (ja) 2019-02-15 2024-03-26 ソール インターナショナル ディベロップメント エルティーディー． 注射可能なフェノール製剤およびその使用の方法
KR102428859B1 (ko) * 2020-05-29 2022-08-04 동성제약주식회사 안전성이 확보된 소화기계 질환 예방 또는 치료를 위한 경구투여용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608258A (en) * 1983-08-17 1986-08-26 Taiko Pharmaceutical Co., Ltd. Medicament for treatment of diarrhea
JPS62142132A (ja) * 1985-12-16 1987-06-25 Tanpei Seiyaku Kk 新規包接化合物

Also Published As

Publication number Publication date
EP0400219A2 (de) 1990-12-05
JPH0625056B2 (ja) 1994-04-06
DE68910676T2 (de) 1994-05-26
HK2194A (en) 1994-01-14
US5112872A (en) 1992-05-12
CA2005072C (en) 1994-12-06
PH27336A (en) 1993-06-08
EP0400219A3 (de) 1991-01-16
JPH0386817A (ja) 1991-04-11
KR910000130A (ko) 1991-01-29
EP0400219B1 (de) 1993-11-10

Similar Documents

Publication Publication Date Title
DE69016900D1 (de) Analysator von Isotopenzusammensetzungen.
ATE121741T1 (de) Piperidinyl-benzimidazole als antihistaminica.
DE69012888D1 (de) Plasminogenaktivator.
DE69020141D1 (de) Verbesserte brillenhalterung.
DE59010314D1 (de) Sulfonylaminocarbonyltriazolinone
DE69020360D1 (de) Zusammensetzung eines elektrolyten auf basis von ceroxid.
DE59000889D1 (de) Verwendung von nicht hydrolysierten n-vinylformamid-einheiten enthaltenden copolymerisaten als flockungs- und entwaesserungsmittel.
DE69024523D1 (de) Integration von planaren, optischen Freiraum-Komponenten
DE68910676T2 (de) Verwendung von Creosot als antispastischer Wirkstoff.
DE68912476T2 (de) Substituierte Thienopyrane als blutdrucksenkendes Mittel.
DE3768352D1 (de) Alkansulfonamide als antiglaucoma-mittel.
FI920423A0 (fi) Foerbaettringar i skaeranordning.
DE3881270T2 (de) Verwendung von pyrrolidon-derivaten als antiamnetikum.
DE59000678D1 (de) Verlegbare bruecke.
DE59005647D1 (de) Verwendung von polyglykolethergemischen als antischaummittel.
DE69010271T2 (de) Regenerierung von verbrauchten Ferrichlorid-Ätzmitteln.
DE68922130T2 (de) Verwendung von 2-Methoxy-4-Propyl-1-Cyclohexanol als Duftstoff.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
DE69616760T2 (de) Verwendung von 4-tert-butyl-1-cyclohexanol als antioxidant
DE69002136D1 (de) Saccharidderivate von protocatechualdehyd.
FI913417A0 (fi) Anordning vid vattensaeng.
DE59004528D1 (de) Verwendung des (+)-enantiomeren von anipamil.
DE68912498T2 (de) Die Verwendung von L-(-)-Menthol als Akarizid.
DE69023747T2 (de) Verwendung von Aminoxiden als antistatischen Agenzien.
DE3777432D1 (de) Verwendung von 2-aminoalkyl-5-pyridinol-verbindungen als nootropika und antidepressiva.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: BARZ, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 80803 MUENCHEN